Article

Anterior segment module receives FDA clearance

Heidelberg Engineering GmbH has been granted FDA clearance for a module that enhances its proprietary spectral-domain optical coherence tomography (OCT) platform by providing a detailed, multi-modality view of the anterior segment (Spectralis Anterior Segment Module).

Heidelberg, Germany-Heidelberg Engineering GmbH has been granted FDA clearance for a module that enhances its proprietary spectral-domain optical coherence tomography (OCT) platform by providing a detailed, multi-modality view of the anterior segment (Spectralis Anterior Segment Module).

The module, which consists of an add-on lens and dedicated software, allows for simultaneous confocal scanning laser ophthalmoscopy and OCT imaging. It is compatible with all models of the proprietary OCT platform.

The module provides high-resolution images of cornea, anterior chamber angle, and sclera. Clinicians can assess both chamber angles at the same time using a 16-mm wide angle-to-angle OCT scan.

“[This module] paves the way towards digital gonioscopy,” said Sanjay Asrani, MD, associate professor of ophthalmology, Duke University Eye Center. “Glaucoma surgeons will further benefit from the enhanced depth imaging OCT capabilities of [the proprietary OCT platform] when assessing filtering blebs and anterior chamber angles.”

For more articles in this issue of Ophthalmology Times eReport, click here.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
(Image credit: Ophthalmology Times) ASCRS 2025: Advancing vitreous care with Inder Paul Singh, MD
(Image credit: Ophthalmology Times) The Residency Report: Study provides new insights into USH2A target end points
Lisa Nijm, MD, says preoperative osmolarity testing can manage patient expectations and improve surgical results at the 2025 ASCRS annual meeting
At the 2025 ASCRS Annual Meeting, Weijie Violet Lin, MD, ABO, shares highlights from a 5-year review of cross-linking complications
Maanasa Indaram, MD, is the medical director of the pediatric ophthalmology and adult strabismus division at University of California San Francisco, and spoke about corneal crosslinking (CXL) at the 2025 ASCRS annual meeting
(Image credit: Ophthalmology Times) ASCRS 2025: Taylor Strange, DO, assesses early visual outcomes with femto-created arcuate incisions in premium IOL cases
(Image credit: Ophthalmology Times) ASCRS 2025: Neda Shamie, MD, shares her early clinical experience with the Unity VCS system
Patricia Buehler, MD, MPH, founder and CEO of Osheru, talks about the Ziplyft device for noninvasive blepharoplasty at the 2025 American Society of Cataract and Refractive Surgeons (ASCRS) annual meeting
(Image credit: Ophthalmology Times) ASCRS 2025: Bonnie An Henderson, MD, on leveraging artificial intelligence in cataract refractive surgery
(Image credit: Ophthalmology Times) ASCRS 2025: Gregory Moloney, FRANZO, FRCSC, on rotational stability
© 2025 MJH Life Sciences

All rights reserved.